Overview

Add-on Therapy With Edupression.Com® on Therapy Resistant Depressive Patients Treated With Nasal Esketamine Spray

Status:
Recruiting
Trial end date:
2022-04-11
Target enrollment:
Participant gender:
Summary
Pragmatic clinical trial of an add-on therapy regarding the use of edupression.com® - a licensed computer based self-help program - on patients with therapy-resistant depression receiving esketamine nasal spray
Phase:
N/A
Details
Lead Sponsor:
Lukas Pezawas
Treatments:
Esketamine